BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
Number Cited Articles
1
M.F. Bassendine, S.U. Nielsen, S.H. Bridge, D.J. Felmlee, D.A. Sheridan, C.J. Packard, R.D. Neely. Hepatitis C virus and atherosclerosis: A legacy after virologic cure?Clinics and Research in Hepatology and Gastroenterology 2017; 41(1): 25 doi: 10.1016/j.clinre.2016.09.008
2
Isabel Conde, Carmen Vinaixa, Marina Berenguer. Cirrosis por hepatitis C. Estado actualMedicina Clínica 2017; 148(2): 78 doi: 10.1016/j.medcli.2016.09.019
3
Simon H. Bridge, Sabrina Pagano, Meleri Jones, Graham R. Foster, Dermot Neely, Nicolas Vuilleumier, Margaret F. Bassendine. Autoantibody to apolipoprotein A-1 in hepatitis C virus infection: a role in atherosclerosis?Hepatology International 2018; 12(1): 17 doi: 10.1007/s12072-018-9842-5
4
Isabel Conde, Carmen Vinaixa, Marina Berenguer. Hepatitis C-related cirrhosis. Current statusMedicina Clínica (English Edition) 2017; 148(2): 78 doi: 10.1016/j.medcle.2016.09.035
5
Amilcar L Morales, Zachary Junga, Manish B Singla, Maria Sjogren, Dawn Torres. Hepatitis C eradication with sofosbuvir leads to significant metabolic changesWorld Journal of Hepatology 2016; 8(35): 1557-1563 doi: 10.4254/wjh.v8.i35.1557
6
Victoria Aguilera, Tommaso Di Maira, Isabel Conde, Victoria Fornés-Ferrer, Carmen Vinaixa, Carmen Pallarés, Angela Carvalho-Gomes, Almudena Cubells, María García, Ángel Rubín, Salvador Benlloch, Luisa Gonzalez-Dieguez, Jose Miguel Molina, Lorena Puchades, F. Xavier López-Labrador, Martin Prieto, Marina Berenguer. Cytomegalovirus reactivation in liver transplant recipients due to hepatitis C cirrhosis is associated with higher cardiovascular risk - an observational, retrospective studyTransplant International 2018; 31(6): 649 doi: 10.1111/tri.13145
7
Ryo Fukuda, Yasuteru Kondo. Hepatitis C virus infection could affect the pathogenesis of ischemic heart diseases in northern JapanHepatology Research 2019; 49(3): 355 doi: 10.1111/hepr.13283
8
Adauto CASTELO, Carlos Eduardo BRANDÃO MELLO, Rosangela TEIXEIRA, Jose Valdez Ramalho MADRUGA, Tania REUTER, Leila Maria Moreira Beltrão PEREIRA, Giovanni Faria SILVA, Mario Reis ÁLVARES-DA-SILVA, Heverton ZAMBRINI, Paulo Roberto Abrão FERREIRA. HEPATITIS C IN THE BRAZILIAN PUBLIC HEALTH CARE SYSTEM: BURDEN OF DISEASEArquivos de Gastroenterologia 2018; 55(4): 329 doi: 10.1590/s0004-2803.201800000-74
9
Frank P. Schmidt, Tim Zimmermann, Till Wenz, Boris Schnorbus, Mir Abolfazl Ostad, Christina Feist, Annette Grambihler, Jörn M. Schattenberg, Martin F. Sprinzl, Thomas Münzel, Peter R. Galle. Interferon- and ribavirin-free therapy with new direct acting antivirals (DAA) for chronic hepatitis C improves vascular endothelial functionInternational Journal of Cardiology 2018; 271: 296 doi: 10.1016/j.ijcard.2018.04.058
10
Ashraf Abd El-Khalik Barakat, Fatma Mohammad Nasr, Amna Ahmed Metwaly, Sherif Morsy, Mervat Eldamarawy. Atherosclerosis in chronic hepatitis C virus patients with and without liver cirrhosisThe Egyptian Heart Journal 2017; 69(2): 139 doi: 10.1016/j.ehj.2016.10.004
11
Mohsen Gadallah, Sahar Kandil, Amira Mohsen. Association between hepatitis C infection and cerebro-cardiovascular disease: analysis of a national population-based survey in EgyptTropical Medicine & International Health 2018; 23(7): 738 doi: 10.1111/tmi.13068
12
Nick Nielsen, Sofie Jespersen, Julie Gaardbo, Caroline Arnbjerg, Mette Clausen, Mette Kjær, Jan Gerstoft, Vibe Ballegaard, Sisse Ostrowski, Susanne Nielsen. Impaired Platelet Aggregation and Rebalanced Hemostasis in Patients with Chronic Hepatitis C Virus InfectionInternational Journal of Molecular Sciences 2017; 18(5): 1016 doi: 10.3390/ijms18051016
13
Fabrizio Fabrizi, Francesca M. Donato, Piergiorgio Messa. Hepatitis C and Its Metabolic Complications in Kidney DiseaseAnnals of Hepatology 2017; 16(6): 851 doi: 10.5604/01.3001.0010.5275